Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q7E9
Term | Name | Level | Count |
---|---|---|---|
GO:0001522 | pseudouridine synthesis | 6 | 11 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006399 | tRNA metabolic process | 7 | 12 |
GO:0006400 | tRNA modification | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008033 | tRNA processing | 8 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009451 | RNA modification | 5 | 11 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0016071 | mRNA metabolic process | 6 | 2 |
GO:0016556 | mRNA modification | 6 | 2 |
GO:0031119 | tRNA pseudouridine synthesis | 7 | 2 |
GO:0034470 | ncRNA processing | 7 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 11 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:1990481 | mRNA pseudouridine synthesis | 7 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0009982 | pseudouridine synthase activity | 4 | 12 |
GO:0016829 | lyase activity | 2 | 7 |
GO:0016853 | isomerase activity | 2 | 12 |
GO:0016866 | intramolecular transferase activity | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0106029 | tRNA pseudouridine synthase activity | 5 | 9 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 9 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 9 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0004730 | pseudouridylate synthase activity | 5 | 1 |
GO:0016835 | carbon-oxygen lyase activity | 3 | 1 |
GO:0016836 | hydro-lyase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 360 | 364 | PF00656 | 0.468 |
CLV_NRD_NRD_1 | 284 | 286 | PF00675 | 0.278 |
CLV_NRD_NRD_1 | 355 | 357 | PF00675 | 0.663 |
CLV_NRD_NRD_1 | 375 | 377 | PF00675 | 0.591 |
CLV_NRD_NRD_1 | 381 | 383 | PF00675 | 0.569 |
CLV_NRD_NRD_1 | 404 | 406 | PF00675 | 0.492 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.372 |
CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.429 |
CLV_PCSK_KEX2_1 | 375 | 377 | PF00082 | 0.591 |
CLV_PCSK_KEX2_1 | 381 | 383 | PF00082 | 0.681 |
CLV_PCSK_KEX2_1 | 406 | 408 | PF00082 | 0.513 |
CLV_PCSK_KEX2_1 | 473 | 475 | PF00082 | 0.413 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.397 |
CLV_PCSK_PC1ET2_1 | 406 | 408 | PF00082 | 0.569 |
CLV_PCSK_PC1ET2_1 | 473 | 475 | PF00082 | 0.419 |
CLV_PCSK_PC7_1 | 371 | 377 | PF00082 | 0.486 |
CLV_PCSK_SKI1_1 | 224 | 228 | PF00082 | 0.325 |
CLV_PCSK_SKI1_1 | 407 | 411 | PF00082 | 0.585 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.441 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.271 |
DEG_APCC_DBOX_1 | 406 | 414 | PF00400 | 0.523 |
DEG_SPOP_SBC_1 | 2 | 6 | PF00917 | 0.599 |
DEG_SPOP_SBC_1 | 424 | 428 | PF00917 | 0.615 |
DOC_CYCLIN_RxL_1 | 92 | 103 | PF00134 | 0.373 |
DOC_MAPK_gen_1 | 60 | 66 | PF00069 | 0.300 |
DOC_MAPK_MEF2A_6 | 257 | 264 | PF00069 | 0.272 |
DOC_MAPK_RevD_3 | 270 | 286 | PF00069 | 0.184 |
DOC_PP2B_LxvP_1 | 270 | 273 | PF13499 | 0.359 |
DOC_USP7_MATH_1 | 129 | 133 | PF00917 | 0.428 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.599 |
DOC_USP7_MATH_1 | 339 | 343 | PF00917 | 0.515 |
DOC_WW_Pin1_4 | 29 | 34 | PF00397 | 0.704 |
DOC_WW_Pin1_4 | 292 | 297 | PF00397 | 0.291 |
LIG_14-3-3_CanoR_1 | 110 | 118 | PF00244 | 0.344 |
LIG_14-3-3_CanoR_1 | 173 | 181 | PF00244 | 0.314 |
LIG_14-3-3_CanoR_1 | 224 | 230 | PF00244 | 0.365 |
LIG_14-3-3_CanoR_1 | 247 | 252 | PF00244 | 0.322 |
LIG_14-3-3_CanoR_1 | 333 | 340 | PF00244 | 0.434 |
LIG_Actin_WH2_2 | 82 | 100 | PF00022 | 0.413 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.762 |
LIG_BIR_III_2 | 136 | 140 | PF00653 | 0.570 |
LIG_BIR_III_4 | 363 | 367 | PF00653 | 0.510 |
LIG_BRCT_BRCA1_1 | 341 | 345 | PF00533 | 0.437 |
LIG_deltaCOP1_diTrp_1 | 384 | 393 | PF00928 | 0.471 |
LIG_EH1_1 | 253 | 261 | PF00400 | 0.271 |
LIG_FHA_1 | 155 | 161 | PF00498 | 0.308 |
LIG_FHA_1 | 286 | 292 | PF00498 | 0.316 |
LIG_FHA_1 | 293 | 299 | PF00498 | 0.316 |
LIG_FHA_1 | 326 | 332 | PF00498 | 0.409 |
LIG_FHA_1 | 349 | 355 | PF00498 | 0.441 |
LIG_FHA_2 | 276 | 282 | PF00498 | 0.394 |
LIG_FHA_2 | 387 | 393 | PF00498 | 0.522 |
LIG_FHA_2 | 4 | 10 | PF00498 | 0.563 |
LIG_FHA_2 | 425 | 431 | PF00498 | 0.738 |
LIG_FHA_2 | 459 | 465 | PF00498 | 0.424 |
LIG_LIR_Apic_2 | 392 | 396 | PF02991 | 0.548 |
LIG_LIR_Gen_1 | 145 | 154 | PF02991 | 0.342 |
LIG_LIR_Gen_1 | 171 | 181 | PF02991 | 0.340 |
LIG_LIR_Gen_1 | 242 | 251 | PF02991 | 0.284 |
LIG_LIR_Gen_1 | 301 | 311 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 171 | 177 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 180 | 186 | PF02991 | 0.293 |
LIG_LIR_Nem_3 | 205 | 211 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 242 | 246 | PF02991 | 0.263 |
LIG_LIR_Nem_3 | 250 | 256 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 301 | 307 | PF02991 | 0.273 |
LIG_LIR_Nem_3 | 342 | 348 | PF02991 | 0.454 |
LIG_MYND_1 | 139 | 143 | PF01753 | 0.502 |
LIG_Pex14_1 | 300 | 304 | PF04695 | 0.256 |
LIG_Pex14_2 | 170 | 174 | PF04695 | 0.312 |
LIG_REV1ctd_RIR_1 | 183 | 192 | PF16727 | 0.368 |
LIG_SH2_CRK | 253 | 257 | PF00017 | 0.256 |
LIG_SH2_PTP2 | 450 | 453 | PF00017 | 0.434 |
LIG_SH2_SRC | 243 | 246 | PF00017 | 0.357 |
LIG_SH2_STAP1 | 462 | 466 | PF00017 | 0.521 |
LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.305 |
LIG_SH2_STAT5 | 184 | 187 | PF00017 | 0.307 |
LIG_SH2_STAT5 | 243 | 246 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 348 | 351 | PF00017 | 0.493 |
LIG_SH2_STAT5 | 412 | 415 | PF00017 | 0.630 |
LIG_SH2_STAT5 | 450 | 453 | PF00017 | 0.374 |
LIG_SH3_3 | 136 | 142 | PF00018 | 0.500 |
LIG_SH3_3 | 284 | 290 | PF00018 | 0.256 |
LIG_SH3_5 | 142 | 146 | PF00018 | 0.369 |
LIG_SUMO_SIM_par_1 | 278 | 284 | PF11976 | 0.390 |
LIG_SUMO_SIM_par_1 | 295 | 301 | PF11976 | 0.208 |
LIG_TRAF2_1 | 194 | 197 | PF00917 | 0.441 |
LIG_TRAF2_1 | 428 | 431 | PF00917 | 0.631 |
LIG_TRAF2_1 | 461 | 464 | PF00917 | 0.490 |
LIG_TYR_ITIM | 241 | 246 | PF00017 | 0.272 |
LIG_TYR_ITIM | 448 | 453 | PF00017 | 0.425 |
LIG_UBA3_1 | 279 | 286 | PF00899 | 0.271 |
LIG_UBA3_1 | 409 | 418 | PF00899 | 0.479 |
MOD_CK1_1 | 19 | 25 | PF00069 | 0.686 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.706 |
MOD_CK1_1 | 32 | 38 | PF00069 | 0.549 |
MOD_CK2_1 | 239 | 245 | PF00069 | 0.261 |
MOD_CK2_1 | 275 | 281 | PF00069 | 0.394 |
MOD_CK2_1 | 424 | 430 | PF00069 | 0.687 |
MOD_CK2_1 | 458 | 464 | PF00069 | 0.395 |
MOD_Cter_Amidation | 470 | 473 | PF01082 | 0.546 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.336 |
MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.579 |
MOD_GlcNHglycan | 335 | 338 | PF01048 | 0.496 |
MOD_GlcNHglycan | 363 | 367 | PF01048 | 0.698 |
MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.648 |
MOD_GlcNHglycan | 441 | 444 | PF01048 | 0.622 |
MOD_GlcNHglycan | 468 | 472 | PF01048 | 0.481 |
MOD_GlcNHglycan | 8 | 13 | PF01048 | 0.612 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.324 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.689 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.394 |
MOD_GSK3_1 | 335 | 342 | PF00069 | 0.480 |
MOD_GSK3_1 | 391 | 398 | PF00069 | 0.564 |
MOD_N-GLC_1 | 217 | 222 | PF02516 | 0.305 |
MOD_N-GLC_2 | 210 | 212 | PF02516 | 0.256 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.741 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.355 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.349 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.140 |
MOD_PIKK_1 | 339 | 345 | PF00454 | 0.413 |
MOD_PIKK_1 | 431 | 437 | PF00454 | 0.764 |
MOD_PKA_1 | 285 | 291 | PF00069 | 0.271 |
MOD_PKA_1 | 356 | 362 | PF00069 | 0.558 |
MOD_PKA_2 | 129 | 135 | PF00069 | 0.350 |
MOD_PKA_2 | 172 | 178 | PF00069 | 0.306 |
MOD_PKA_2 | 332 | 338 | PF00069 | 0.414 |
MOD_PKA_2 | 455 | 461 | PF00069 | 0.393 |
MOD_Plk_1 | 458 | 464 | PF00069 | 0.407 |
MOD_Plk_1 | 8 | 14 | PF00069 | 0.560 |
MOD_Plk_1 | 82 | 88 | PF00069 | 0.466 |
MOD_Plk_2-3 | 239 | 245 | PF00069 | 0.256 |
MOD_Plk_4 | 145 | 151 | PF00069 | 0.409 |
MOD_Plk_4 | 247 | 253 | PF00069 | 0.346 |
MOD_Plk_4 | 271 | 277 | PF00069 | 0.355 |
MOD_ProDKin_1 | 29 | 35 | PF00069 | 0.705 |
MOD_ProDKin_1 | 292 | 298 | PF00069 | 0.291 |
MOD_SUMO_rev_2 | 281 | 288 | PF00179 | 0.261 |
MOD_SUMO_rev_2 | 428 | 434 | PF00179 | 0.663 |
MOD_SUMO_rev_2 | 478 | 485 | PF00179 | 0.451 |
TRG_DiLeu_BaEn_1 | 261 | 266 | PF01217 | 0.294 |
TRG_DiLeu_BaEn_4 | 464 | 470 | PF01217 | 0.411 |
TRG_DiLeu_BaLyEn_6 | 293 | 298 | PF01217 | 0.353 |
TRG_DiLeu_BaLyEn_6 | 449 | 454 | PF01217 | 0.537 |
TRG_DiLeu_BaLyEn_6 | 95 | 100 | PF01217 | 0.335 |
TRG_ENDOCYTIC_2 | 146 | 149 | PF00928 | 0.320 |
TRG_ENDOCYTIC_2 | 183 | 186 | PF00928 | 0.435 |
TRG_ENDOCYTIC_2 | 243 | 246 | PF00928 | 0.263 |
TRG_ENDOCYTIC_2 | 253 | 256 | PF00928 | 0.243 |
TRG_ENDOCYTIC_2 | 450 | 453 | PF00928 | 0.374 |
TRG_ER_diArg_1 | 374 | 376 | PF00400 | 0.599 |
TRG_ER_diArg_1 | 380 | 382 | PF00400 | 0.571 |
TRG_ER_diArg_1 | 474 | 477 | PF00400 | 0.402 |
TRG_ER_diArg_1 | 94 | 96 | PF00400 | 0.350 |
TRG_NLS_MonoExtC_3 | 471 | 476 | PF00514 | 0.410 |
TRG_NLS_MonoExtN_4 | 472 | 477 | PF00514 | 0.408 |
TRG_Pf-PMV_PEXEL_1 | 257 | 261 | PF00026 | 0.348 |
TRG_Pf-PMV_PEXEL_1 | 98 | 102 | PF00026 | 0.382 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IA61 | Leptomonas seymouri | 70% | 97% |
A0A0S4JB03 | Bodo saltans | 50% | 100% |
A0A1X0P1U9 | Trypanosomatidae | 58% | 100% |
A0A3S7X3E8 | Leishmania donovani | 95% | 100% |
A0A422P3K1 | Trypanosoma rangeli | 59% | 100% |
A4HIA0 | Leishmania braziliensis | 83% | 100% |
A4I5I4 | Leishmania infantum | 94% | 100% |
C9ZQW8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
E9B0S9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q09524 | Caenorhabditis elegans | 34% | 100% |
V5DQN1 | Trypanosoma cruzi | 59% | 94% |